-
Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene
Post on 1/7/19
-
Should Celgene Investors Take Bristol's Money and Run?
Post on 1/7/19
-
Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene
Post on 1/7/19
-
Bristol-Myers: Analysis On Celgene Deal
Post on 1/4/19
-
Here’s What Celgene Shareholders Are Getting From Bristol-Myers Squibb
Post on 1/4/19
-
Knopp Biosciences Enters Research Collaboration with Baylor College of Medicine
Post on 1/3/19
-
Knopp Biosciences Enters Research Collaboration with Baylor College of Medicine
Post on 1/3/19
-
Conduent Completes Acquisition of Health Solutions Plus
Post on 1/3/19
-
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Post on 1/3/19
-
Hackensack Meridian Health and Carrier Clinic Merge
Post on 1/3/19
-
Integral Molecular Announces Antibody Discovery Collaboration with Ono Pharmaceutical
Post on 1/3/19
-
Kashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciences
Post on 1/3/19
-
Bristol-Myers Squibb To Acquire Celgene
Post on 1/3/19
-
Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product
Post on 1/3/19
-
Alliqua Biomedical CEO Provides Shareholder Update
Post on 1/3/19
-
AmerisourceBergen With Cash Flow Secured Trades At 10-Year Low Valuation
Post on 1/3/19
-
Hikma Pharmaceutical Plants Sold to Investor Group
Post on 1/2/19
-
Intact Vascular Announces Enrollment Completion of TOBA II BTK Clinical Trial
Post on 1/2/19
-
Recro Pharma Amends Athyrium Credit Facility
Post on 1/2/19
-
JHU Spinout WindMIL Therapeutics Expands to Philly, Adds Two New Executives
Post on 1/1/19
-
Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership
Post on 1/1/19
-
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
Post on 12/21/18
-
Pfizer: Consumer Health Deal Looks Good
Post on 12/21/18
-
Johnson & Johnson: Buy The Dip? A 2-Point Analysis
Post on 12/21/18
-
Pfizer: Steady As She Goes
Post on 12/21/18